Gilead Sciences, Inc.
Sector: Manufacturing
Industry: Pharmaceutical Products
106.76
0.38
(0.36%)
Volume:
3,805,830
52 week range:
59.82 - 119.12
Market Cap:
132.480B
Company Description:
Gilead Sciences discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, and Atripla products for the treatment of HIV/AIDS.